We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$236M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$31.2M
3
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
+$25M
4
AMAT icon
Applied Materials
AMAT
+$22.1M
5
BAX icon
Baxter International
BAX
+$20.4M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
51
Medtronic
MDT
$108B
$64.9M 0.28%
517,721
+55,870
+12% +$7.23M
XOM icon
52
ExxonMobil
XOM
$642B
$64.6M 0.28%
1,098,565
+106,323
+11% +$6.06M
AESC
53
DELISTED
The AES Corporation
AESC
$64.4M 0.28%
668,295
+298,856
+81% +$30.3M
PEP icon
54
PepsiCo
PEP
$191B
$61.1M 0.27%
406,174
+25,321
+7% +$3.92M
MRK icon
55
Merck
MRK
$323B
$60.8M 0.27%
809,768
+50,329
+7% +$3.83M
MCD icon
56
McDonald's
MCD
$192B
$59.8M 0.26%
247,932
+16,311
+7% +$3.89M
ABT icon
57
Abbott
ABT
$182B
$58.6M 0.26%
496,052
+81,836
+20% +$10.1M
PAYC icon
58
Paycom
PAYC
$7.05B
$58.2M 0.25%
117,426
-25,050
-18% -$11.2M
ABBV icon
59
AbbVie
ABBV
$454B
$57.3M 0.25%
531,451
+62,014
+13% +$7.09M
LOW icon
60
Lowe's Companies
LOW
$119B
$57.2M 0.25%
281,903
+18,706
+7% +$3.73M
BMY icon
61
Bristol-Myers Squibb
BMY
$128B
$55.6M 0.24%
940,365
+143,994
+18% +$9.48M
C icon
62
Citigroup
C
$223B
$55.6M 0.24%
792,023
+39,371
+5% +$2.75M
CFXA
63
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
$54.8M 0.24%
293,520
-10,000
-3% -$1.89M
ALC icon
64
Alcon
ALC
$32.8B
$54.5M 0.24%
677,016
+2,995
+0.4% +$231K
NEE.PRQ
65
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
$54M 0.24%
1,055,878
-20
-0% -$1.06K
MRSH
66
Marsh
MRSH
$87.5B
$53.6M 0.23%
353,816
+13,715
+4% +$2.07M
SNAP icon
67
PUT
Snap
SNAP
$7.6B
$52.8M 0.23%
715,000
– –
MDLZ icon
68
Mondelez International
MDLZ
$77.9B
$50.3M 0.22%
864,829
+24,429
+3% +$1.52M
TGT icon
69
Target
TGT
$63.7B
$49.7M 0.22%
217,252
+14,390
+7% +$3.6M
DHR icon
70
Danaher
DHR
$138B
$49.7M 0.22%
184,091
-26,203
-12% -$7.13M
A icon
71
Agilent Technologies
A
$38.9B
$49M 0.21%
311,077
+22,533
+8% +$3.64M
ORCL icon
72
Oracle
ORCL
$345B
$48.7M 0.21%
559,291
-71,800
-11% -$6.34M
VZ icon
73
Verizon
VZ
$198B
$48.7M 0.21%
901,408
+81,596
+10% +$4.51M
T icon
74
AT&T
T
$167B
$48.4M 0.21%
2,374,357
+178,564
+8% +$3.75M
BSX icon
75
Boston Scientific
BSX
$67.6B
$47.5M 0.21%
1,095,127
-55,354
-5% -$2.45M
1 2
3
4 5

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.